BIOENGINEERING TECHNOLOGIES

BIO-
ENGINEERING
TECHNOLOGIES

Drug developers need better tools to make better medicines

Fig.01
T Cell

Optimized enveloped vector surface compositions for high-efficiency, cell type specific delivery

Fig.02
Retroviral Integrase

Delivery systems compatible with a variety of programmable cell engineering payload types

Jay Rosanelli

Co-Founder & CEO

Josh Leonard

Co-Founder & CSO

Matteo Stoppato

Senior Director, R&D

Teresa Nikolich

Associate Director, Operations

Devin Stranford

Scientist II

Hailey Edelstein

Scientist II

Join our exceptional team of multidisciplinary experts dedicated to continuous innovation and open collaboration with drug developers